WHO WE ARE →

WHAT WE DO →

OUR STORIES →

THE KIDNEY CANCER COMMUNITY →

SCIENTIFIC ADVISORS →

DONATE →

CONTACT →

Latest News

Leah Christoforidis: Rare Kidney Cancer and Her Advocacy for Research

Leah Christoforidis: Rare Kidney Cancer and Her Advocacy for Research

Meet Leah Christoforidis, a resilient Illinois resident and mother of four, whose life took an unexpected turn when diagnosed with a rare form of kidney cancer during her pregnancy. In this month's Community Spotlight, Leah shares her compelling journey from diagnosis to advocacy, revealing how...

SPRING ADVOCACY DAYS 2024 →

JOIN OUR COMMUNITY →

RAISING AWARENESS →

BE AN ADVOCATE →

DONATE NOW →

CONTACT →

Latest News

Leah Christoforidis: Rare Kidney Cancer and Her Advocacy for Research

Leah Christoforidis: Rare Kidney Cancer and Her Advocacy for Research

Meet Leah Christoforidis, a resilient Illinois resident and mother of four, whose life took an unexpected turn when diagnosed with a rare form of kidney cancer during her pregnancy. In this month's Community Spotlight, Leah shares her compelling journey from diagnosis to advocacy, revealing how...

KCRS: KIDNEY CANCER RESEARCH SUMMIT →

RESEARCH OPPORTUNITIES →

NEWS →

Latest News

Renée Maria Saliby: Kidney Cancer Research Champion

Renée Maria Saliby: Kidney Cancer Research Champion

Introducing Renée Maria Saliby, a dedicated young investigator in kidney cancer research! At just 27, Renée is blazing an inspring professional trail. Read on as she shares insights from her personal experiences and career pursuits, along with opportunities available for young researchers to...

SUPPORT OUR WORK →
ROCK THE RUN 2024 →
FUNDRAISE FOR KIDNEYCAN →
DONATE →
CONTACT →

Latest News

Leah Christoforidis: Rare Kidney Cancer and Her Advocacy for Research

Leah Christoforidis: Rare Kidney Cancer and Her Advocacy for Research

Meet Leah Christoforidis, a resilient Illinois resident and mother of four, whose life took an unexpected turn when diagnosed with a rare form of kidney cancer during her pregnancy. In this month's Community Spotlight, Leah shares her compelling journey from diagnosis to advocacy, revealing how...

Partners in Progress: Real Talk on Clinical Trials

Kidney cancer patients and leading researchers discuss the clinical trials journey at our latest Town Hall.

Looking Back, Looking Forward with the Uromigos

Renowned clinical kidney cancer researchers (and GU podcast fan favorites!) Brian Rini and Tom Powles presented research updates at KidneyCAN’s annual research Town Hall.

Spring Advocacy Days

KidneyCAN’s Spring Advocacy Days was a pivotal event where all stakeholders — patients, caregivers, doctors, researchers — spoke with one voice to ask Congress to fund kidney cancer research. Join us this fall for the next event!

Patient Resource Center

A kidney cancer diagnosis can be scary and confusing. You’re not alone. KidneyCAN has put together valuable resources to help you navigate a new diagnosis, your treatment options, and living well with cancer.

Kidney Cancer & the Military: Understanding the Connection

Military personnel are at a higher risk for developing kidney cancer due to exposure to toxins. Learn how the 2022 PACT Act helps veterans with kidney cancer.

Kidney Cancer Research Summit

KCRS24 is slated for July 11-12 in Boston, MA! Register now to grab your free virtual seat. You can now view video and slides from KCRS23.
Making Progress Toward Cures

Our Goals

  • Provide education, resources, and support to kidney cancer patients and caregivers
  • Identify patients’ and researchers’ unmet needs
  • Engage and educate policymakers on the urgency of kidney cancer research funding
  • Urge Congress to fund kidney cancer research
  • Increase CDMRP Kidney Cancer Research Program and NIH funding through advocacy
  • Provide direct funding to promising ideas
  • Propel collaboration and progress in kidney cancer research (Kidney Cancer Research Summit)
  • Grow the community of kidney cancer researchers
  • Support the development of new treatments by educating patients on trial access and enrollment
  • Identify new unmet needs, set new goals, and keep working

Our Mission

Our mission is to accelerate cures for kidney cancer. We engage in patient advocacy and power research by supporting government and industry research funding, facilitating research collaborations, and offering direct financial support for clinical and laboratory researchers with promising ideas. Together, we can find the cure.

NEWLY DIAGNOSED?

You’re not alone. We’ve put together a Patient Resource Center to help you navigate a new diagnosis and beyond. Learn about kidney cancer, various treatment options, patient education events, and how to live well with cancer.  

BUILD A CARE TEAM

One of the best decisions you can make when facing kidney cancer is to choose an experienced medical team. We’ve put together resources including a checklist of questions for your doctor and a list of NCI comprehensive cancer centers.

Understanding Your Kidney Cancer Diagnosis

GO TO PAGE

Visit

Building a Care Team

GO TO PAGE

Visit

Treatment & Trial Options

GO TO PAGE

Visit

Living Well with Kidney Cancer

GO TO PAGE

Visit

Join Our Grassroots Army

You might not realize how important it is for the kidney cancer community to advocate in order to make progress toward cures.

What are we advocating for?

Awareness? Funding? Research? Cures?

The answer is — we are advocating for all of those things. We know that awareness of kidney cancer and its impact on many lives leads to a sense of urgency, a desire for solutions. Awareness leads to advocacy, and advocacy — joining to speak as one voice — leads to funding and research. That’s how we get to cures.

A timely and clinically relevant review!
This review provides crucial insights into the treatment of metastatic renal cell carcinoma (mRCC). Congratulations to the entire team on this important contribution! 👏👏👏 @ASCO @DrChoueiri @NazliDizman @yekeduz_emre @MarcMachaalani

💫🌟 New insights on immunotherapy rechallenge in mRCC!
@OncoAlert
🌟 Key takeaways:

- 📊 CONTACT-03 trial: Negative results for combining cabozantinib with atezolizumab post-ICI, raising questions on ICI rechallenge strategies.
- 🔄 TiNivo-2 trial: Awaiting results... on PD-1

Just in @KCA_Journal👉Interesting systematic review by #AlfredoDistante @SMuselaers on pt selection for active surveillance of small renal masses #kidneycancer👉Age, cardiovascular index & CKD were associated with⬇️OS👇
https://t.co/4YOBdDnJv0 @OncoAlert @urotoday @kidneycan

@DanaFarber_GU @BradMcG04 @bergsa83 @aboutKP @DukeCancer @Daniel_J_George @UofOklahoma @AbhiTrip87 @utswcancer @SuzanneColeMD @NCICTEP_ClinRes @theNCI We cannot do these large trials without the support & buy-in from our patients who generously have their time, data, and trusted their lives ...& disease courses onto the protocol. Thanks @kcCURE @KidneyCancer @kidneycan groups for always supporting the patients who signed up!!

.@FamilyVhl will be hosting a webinar on 'Sporadic and Inherited Kidney Cancer (Von-Hippel Lindau) focusing on the patient' on Wednesday 22nd May at 17:15 - 22:30 EEST. Learn more at https://t.co/4T7VtgpnsY #KidneyCancer

Just in @KCA_Journal 👉Excellent review by @AJangMD @ShilpaOnc on papillary RCC #kidneycancer👉Despite improved outcomes with VEGF-TKIs and ICIs, more dedicated clinical trials to pRCC are urgently needed👇
https://t.co/O3IgaMOHJq @urotoday @OncoAlert @kidneycan @KidneyCancer

Best Diet Practices for Kidney Cancer Patients | Dr. Hans Hammers & Dr. Matthew Abramson Share

When we formed KidneyCAN in 2016, the amount of money Congress allocated specifically for kidney cancer research was $0. Through advocacy, we’ve generated $235 million in research funding in six years. That’s the power of a unified voice!

Latest News

Leah Christoforidis: Rare Kidney Cancer and Her Advocacy for Research

Meet Leah Christoforidis, a resilient Illinois resident and mother of four, whose life took an unexpected turn when diagnosed with a rare form of kidney cancer during her pregnancy. In this month's Community Spotlight, Leah shares her compelling journey from diagnosis...

Renée Maria Saliby: Kidney Cancer Research Champion

Introducing Renée Maria Saliby, a dedicated young investigator in kidney cancer research! At just 27, Renée is blazing an inspring professional trail. Read on as she shares insights from her personal experiences and career pursuits, along with opportunities available...

Empowering Young Voices: The Role of Youth in Kidney Cancer Advocacy

Scarlett Talcott, a vibrant 11-year-old from southern Montana, stands confidently in front of the Capitol Building during KidneyCAN's Advocacy Day. Living on a ranch with her parents, sister, and two brothers, Scarlett balances her love for the arts, crafting, and 4-H...

Voices of Resilience: Navigating Kidney Cancer in Veteran and Native American Communities

On the outskirts of Tulsa, Oklahoma, Maggie Burns stands as a testament to resilience and advocacy within the kidney cancer community. A caregiver to her husband, Ron Stanton, Maggie is a proud member of the Cherokee Nation and a retired IT professional. Maggie's life...

KidneyCAN is a registered 501(c)(3) nonprofit and does not receive any funding through the Congressionally Directed Medical Research Program (CDMRP) or KCRP (Kidney Cancer Research Program). Our work is funded by grassroots donors in the kidney cancer community.